FindTrial
Sign In

Benefits Of PET Scan in Gall Bladder Cancer

Role of PET (positron emission tomography) in GBCs (gall bladder cancers)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2017/12/010849
Enrollment
150
Registered
2017-12-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patients with Gall bladder cancer without clinical metastasis

Interventions

Control Intervention1: PET scan: PET scan is a non invasive radiological diagnostic modality done to know about distant metastasis.

Sponsors

Dr Shivendra Singh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients with clinical or pathological diagnosis of GBC without metastasis. Locally resectable GBC on CT/ MRI scan.

Exclusion criteria

Exclusion criteria: Clinical or radiological metastatic disease with GBC; Incidental GBC; Previous surgery for GBC; Recurrent GBC; Locally advanced unresectable GBC; Refused consent for PET scan.

Design outcomes

Primary

MeasureTime frame
Whether there is change in management plan based on PET scan findings in GBC .Timepoint: once preoperatively—

Secondary

MeasureTime frame
To detect metaststic disease elsewhere in the body though PET scanTimepoint: Once preoperatively—

Countries

India

Contacts

Public ContactDr Shivendra Singh

Rajiv Gandhi Cancer Research Institute

singh.shivendra@rgcirc.org9818975024

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026